A Q&A article in Outsourcing Pharma featuring commentary from Kerina Bonar, discussing the challenges and advantages of hybrid study designs. The article explores how designing studies with epidemiological input can be beneficial for real world evidence generation and ensuring a study design is fit for purpose.